The File Doctor Limited Filleted accounts for Companies House (small and micro)

THE FILE DOCTOR LIMITED - Company Information

0 false false false false false false false false false true false false false false false false No description of principal activity 2020-07-01 Sage Accounts Production Advanced 2020 - FRS102_2019 xbrli:pure xbrli:shares iso4217:GBP 05870552 2020-07-01 2021-04-30 05870552 2021-04-30 05870552 2020-06-30 05870552 bus:Director1 2020-07-01 2021-04-30 05870552 core:WithinOneYear 2021-04-30 05870552 core:WithinOneYear 2020-06-30 05870552 core:ShareCapital 2021-04-30 05870552 core:ShareCapital 2020-06-30 05870552 core:RetainedEarningsAccumulatedLosses 2020-06-30 05870552 bus:Director1 2020-06-30 05870552 bus:Director1 2021-04-30 05870552 bus:Director1 2019-06-30 05870552 bus:Director1 2020-06-30 05870552 bus:Director1 2019-07-01 2020-06-30 05870552 bus:SmallEntities 2020-07-01 2021-04-30 05870552 bus:AuditExemptWithAccountantsReport 2020-07-01 2021-04-30 05870552 bus:FullAccounts 2020-07-01 2021-04-30 05870552 bus:SmallCompaniesRegimeForAccounts 2020-07-01 2021-04-30 05870552 bus:PrivateLimitedCompanyLtd 2020-07-01 2021-04-30

COMPANY REGISTRATION NUMBER: 05870552

The File Doctor Limited

Filleted Unaudited Financial Statements

30 April 2021

The File Doctor Limited

Financial Statements

Period from 1 July 2020 to 30 April 2021

Contents	Page

Statement of financial position	1

Notes to the financial statements	2

The File Doctor Limited

Statement of Financial Position

30 April 2021

	30 Apr 21		30 Jun 20
Note	£	£	£

Current assets

Cash at bank and in hand	19,487		7,241

Creditors: amounts falling due within one year	4	19,486		3,418
		--------		-------
Net current assets			1	3,823
			----	-------
Total assets less current liabilities			1	3,823
			----	-------
Net assets			1	3,823
			----	-------

Capital and reserves

Called up share capital	1	1
Profit and loss account	–	3,822
	----	-------
Shareholders funds	1	3,823
	----	-------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the period ending 30 April 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;

- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

These financial statements were approved by the board of directors and authorised for issue on 16 August 2021 , and are signed on behalf of the board by:

Mrs D Leivers
Director

Company registration number: 05870552

The File Doctor Limited

Notes to the Financial Statements

Period from 1 July 2020 to 30 April 2021

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is H1, Ash Tree Court, Mellors Way, Nottingham Business Park, Nottingham, NG8 6PY, United Kingdom.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Creditors: amounts falling due within one year

	30 Apr 21	30 Jun 20
	£	£
Corporation tax	2,371	1,357
Social security and other taxes	2,665	1,302
Other creditors	14,450	759
	--------	-------
	19,486	3,418
	--------	-------

5. Director's advances, credits and guarantees

During the period the director entered into the following advances and credits with the company:

	30 Apr 21
	Balance brought forward	Advances/ (credits) to the director	Amounts repaid	Balance outstanding
	£	£	£	£
Mrs D Leivers	( 6)	360	( 14,090)	( 13,736)
	----	----	--------	--------

	30 Jun 20
	Balance brought forward	Advances/ (credits) to the director	Amounts repaid	Balance outstanding
	£	£	£	£
Mrs D Leivers	( 99)	5,087	( 4,994)	( 6)
	----	-------	-------	----

6. Related party transactions

Ordinary dividends paid to the director were £13,169 (30.06.20 - £2,800).